Teva Pharmaceutical Industries stock is trading -26.74% below its average target price of $22.88 after dropping -1.5% during today's afternoon session. Analysts are giving the Large-Cap Pharmaceutical company an average rating of buy and target prices ranging from $18.07 to $30.0 per share.
Teva Pharmaceutical Industries's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 2.5%. The stock's short ratio is 2.31. At 0.0%, the company's rate of insider ownership does not indicate that management is heavily invested in the corporation.
Another number to watch is the company's rate of institutional share ownership, which now stands at 64.1%. In conclusion, we believe there is mixed market sentiment regarding Teva Pharmaceutical Industries.
Institutions Invested in Teva Pharmaceutical Industries
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-03-31 | FMR, LLC | 7% | 82,742,016 | $1,387,169,847 |
| 2025-03-31 | Blackrock Inc. | 5% | 52,223,893 | $875,533,534 |
| 2025-03-31 | Clal Insurance Enterprises Holdings Ltd | 3% | 37,794,068 | $633,617,526 |
| 2025-03-31 | Menora Mivtachim Holdings Ltd. | 3% | 29,189,316 | $489,358,864 |
| 2025-03-31 | Lingotto Investment Management LLP | 2% | 27,853,943 | $466,971,337 |
| 2025-03-31 | Phoenix Financial Ltd. | 2% | 27,464,572 | $460,443,532 |
| 2025-03-31 | Migdal Insurance & Financial Holdings Ltd. | 2% | 26,335,422 | $441,513,333 |
| 2025-03-31 | Rubric Capital Management LP | 2% | 25,550,000 | $428,345,734 |
| 2025-03-31 | Harel Insurance Investments & Financial Services Ltd. | 2% | 22,055,547 | $369,761,231 |
| 2025-03-31 | State Street Corporation | 2% | 17,321,325 | $290,392,003 |
